By contrast, TB amplification in breast cancer appears to occur in already-aneuploid breast cells, often harbouring driver point mutations49; furthermore, E2–ERα antagonizes the p53-induced apoptosis in breast cancer cells50. Here, TP53 is linked to breast carcinoma.